This announcement is a separate document:
武田薬品工業：（訂正）2024年３月期決算短信〔IFRS〕（連結）の一部訂正について
Takeda Pharmaceutical: (Correction) Partial revisions to financial results summary [IFRS] (consolidated) for the fiscal year ending March 31, 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.